Industry: Medical Devices & Consumables
Published Date: 2026-07-14
Pages: 153 Pages
Report ld: 6931877
Request Sample
Customized Report
The global market for Bionic Exoskeletons was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
The North American market for Bionic Exoskeletons was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Bionic Exoskeletons was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Bionic Exoskeletons was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Bionic Exoskeletons market include Ekso Bionics, Ottobock Inc, DJO Global Inc., Ossur Corporate, Rex Bionics Ltd., Alter G, ReWalk Robotics, Axosuits, EduExo, Festo, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Bionic Exoskeletons, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Bionic Exoskeletons market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Bionic Exoskeletons.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Bionic Exoskeletons manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Bionic Exoskeletons sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Bionic Exoskeletons sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Bionic Exoskeletons Product Introduction
1.2 Global Bionic Exoskeletons Market Size Forecast
1.2.1 Global Bionic Exoskeletons Sales Value (2021–2032)
1.2.2 Global Bionic Exoskeletons Sales Volume (2021–2032)
1.2.3 Global Bionic Exoskeletons Sales Price (2021–2032)
1.3 Bionic Exoskeletons Market Trends & Drivers
1.3.1 Bionic Exoskeletons Industry Trends
1.3.2 Bionic Exoskeletons Market Drivers & Opportunities
1.3.3 Bionic Exoskeletons Market Challenges
1.3.4 Bionic Exoskeletons Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Bionic Exoskeletons Players Revenue Ranking (2025)
2.2 Global Bionic Exoskeletons Revenue by Company (2021–2026)
2.3 Global Bionic Exoskeletons Sales Volume Ranking of Players (2025)
2.4 Global Bionic Exoskeletons Sales Volume by Company (2021–2026)
2.5 Global Bionic Exoskeletons Average Price by Company (2021–2026)
2.6 Key Manufacturers Bionic Exoskeletons Manufacturing Base and Headquarters
2.7 Key Manufacturers Bionic Exoskeletons Product Offerings
2.8 Key Manufacturers Start of Mass Production of Bionic Exoskeletons
2.9 Bionic Exoskeletons Market Competitive Analysis
2.9.1 Bionic Exoskeletons Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Bionic Exoskeletons Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Bionic Exoskeletons revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Bionic Exoskeletons Market Classification
3.1 Introduction by Type
3.1.1 Active Exoskeletons
3.1.2 Passive Exoskeletons
3.1.3 Global Bionic Exoskeletons Sales Value by Type
3.1.3.1 Global Bionic Exoskeletons Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Bionic Exoskeletons Sales Value, by Type (2021–2032)
3.1.3.3 Global Bionic Exoskeletons Sales Value, by Type (%), 2021–2032
3.1.4 Global Bionic Exoskeletons Sales Volume by Type
3.1.4.1 Global Bionic Exoskeletons Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Bionic Exoskeletons Sales Volume, by Type (2021–2032)
3.1.4.3 Global Bionic Exoskeletons Sales Volume, by Type (%), 2021–2032
3.1.5 Global Bionic Exoskeletons Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Medical
4.1.2 Military
4.2 Global Bionic Exoskeletons Sales Value by Application
4.2.1 Global Bionic Exoskeletons Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Bionic Exoskeletons Sales Value, by Application (2021–2032)
4.2.3 Global Bionic Exoskeletons Sales Value, by Application (%), 2021–2032
4.3 Global Bionic Exoskeletons Sales Volume by Application
4.3.1 Global Bionic Exoskeletons Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Bionic Exoskeletons Sales Volume, by Application (2021–2032)
4.3.3 Global Bionic Exoskeletons Sales Volume, by Application (%), 2021–2032
4.4 Global Bionic Exoskeletons Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Bionic Exoskeletons Sales Value by Region
5.1.1 Global Bionic Exoskeletons Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Bionic Exoskeletons Sales Value by Region (2021–2026)
5.1.3 Global Bionic Exoskeletons Sales Value by Region (2027–2032)
5.1.4 Global Bionic Exoskeletons Sales Value by Region (%), 2021–2032
5.2 Global Bionic Exoskeletons Sales Volume by Region
5.2.1 Global Bionic Exoskeletons Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Bionic Exoskeletons Sales Volume by Region (2021–2026)
5.2.3 Global Bionic Exoskeletons Sales Volume by Region (2027–2032)
5.2.4 Global Bionic Exoskeletons Sales Volume by Region (%), 2021–2032
5.3 Global Bionic Exoskeletons Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Bionic Exoskeletons Sales Value, 2021–2032
5.4.2 North America Bionic Exoskeletons Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Bionic Exoskeletons Sales Value, 2021–2032
5.5.2 Europe Bionic Exoskeletons Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Bionic Exoskeletons Sales Value, 2021–2032
5.6.2 Asia Pacific Bionic Exoskeletons Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Bionic Exoskeletons Sales Value, 2021–2032
5.7.2 South America Bionic Exoskeletons Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Bionic Exoskeletons Sales Value, 2021–2032
5.8.2 Middle East & Africa Bionic Exoskeletons Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Bionic Exoskeletons Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Bionic Exoskeletons Sales Value and Sales Volume
6.2.1 Key Countries/Regions Bionic Exoskeletons Sales Value, 2021–2032
6.2.2 Key Countries/Regions Bionic Exoskeletons Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Bionic Exoskeletons Sales Value, 2021–2032
6.3.2 United States Bionic Exoskeletons Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Bionic Exoskeletons Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Bionic Exoskeletons Sales Value, 2021–2032
6.4.2 Europe Bionic Exoskeletons Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Bionic Exoskeletons Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Bionic Exoskeletons Sales Value, 2021–2032
6.5.2 China Bionic Exoskeletons Sales Value by Type (%), 2025 vs 2032
6.5.3 China Bionic Exoskeletons Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Bionic Exoskeletons Sales Value, 2021–2032
6.6.2 Japan Bionic Exoskeletons Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Bionic Exoskeletons Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Bionic Exoskeletons Sales Value, 2021–2032
6.7.2 South Korea Bionic Exoskeletons Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Bionic Exoskeletons Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Bionic Exoskeletons Sales Value, 2021–2032
6.8.2 Southeast Asia Bionic Exoskeletons Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Bionic Exoskeletons Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Bionic Exoskeletons Sales Value, 2021–2032
6.9.2 India Bionic Exoskeletons Sales Value by Type (%), 2025 vs 2032
6.9.3 India Bionic Exoskeletons Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Ekso Bionics
7.1.1 Ekso Bionics Company Information
7.1.2 Ekso Bionics Introduction and Business Overview
7.1.3 Ekso Bionics Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Ekso Bionics Bionic Exoskeletons Product Offerings
7.1.5 Ekso Bionics Recent Developments
7.2 Ottobock Inc
7.2.1 Ottobock Inc Company Information
7.2.2 Ottobock Inc Introduction and Business Overview
7.2.3 Ottobock Inc Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Ottobock Inc Bionic Exoskeletons Product Offerings
7.2.5 Ottobock Inc Recent Developments
7.3 DJO Global Inc.
7.3.1 DJO Global Inc. Company Information
7.3.2 DJO Global Inc. Introduction and Business Overview
7.3.3 DJO Global Inc. Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 DJO Global Inc. Bionic Exoskeletons Product Offerings
7.3.5 DJO Global Inc. Recent Developments
7.4 Ossur Corporate
7.4.1 Ossur Corporate Company Information
7.4.2 Ossur Corporate Introduction and Business Overview
7.4.3 Ossur Corporate Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Ossur Corporate Bionic Exoskeletons Product Offerings
7.4.5 Ossur Corporate Recent Developments
7.5 Rex Bionics Ltd.
7.5.1 Rex Bionics Ltd. Company Information
7.5.2 Rex Bionics Ltd. Introduction and Business Overview
7.5.3 Rex Bionics Ltd. Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Rex Bionics Ltd. Bionic Exoskeletons Product Offerings
7.5.5 Rex Bionics Ltd. Recent Developments
7.6 Alter G
7.6.1 Alter G Company Information
7.6.2 Alter G Introduction and Business Overview
7.6.3 Alter G Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Alter G Bionic Exoskeletons Product Offerings
7.6.5 Alter G Recent Developments
7.7 ReWalk Robotics
7.7.1 ReWalk Robotics Company Information
7.7.2 ReWalk Robotics Introduction and Business Overview
7.7.3 ReWalk Robotics Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 ReWalk Robotics Bionic Exoskeletons Product Offerings
7.7.5 ReWalk Robotics Recent Developments
7.8 Axosuits
7.8.1 Axosuits Company Information
7.8.2 Axosuits Introduction and Business Overview
7.8.3 Axosuits Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Axosuits Bionic Exoskeletons Product Offerings
7.8.5 Axosuits Recent Developments
7.9 EduExo
7.9.1 EduExo Company Information
7.9.2 EduExo Introduction and Business Overview
7.9.3 EduExo Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 EduExo Bionic Exoskeletons Product Offerings
7.9.5 EduExo Recent Developments
7.10 Festo
7.10.1 Festo Company Information
7.10.2 Festo Introduction and Business Overview
7.10.3 Festo Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Festo Bionic Exoskeletons Product Offerings
7.10.5 Festo Recent Developments
7.11 Lockheed Martin
7.11.1 Lockheed Martin Company Information
7.11.2 Lockheed Martin Introduction and Business Overview
7.11.3 Lockheed Martin Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Lockheed Martin Bionic Exoskeletons Product Offerings
7.11.5 Lockheed Martin Recent Developments
7.12 BAE Systems
7.12.1 BAE Systems Company Information
7.12.2 BAE Systems Introduction and Business Overview
7.12.3 BAE Systems Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 BAE Systems Bionic Exoskeletons Product Offerings
7.12.5 BAE Systems Recent Developments
7.13 Raytheon
7.13.1 Raytheon Company Information
7.13.2 Raytheon Introduction and Business Overview
7.13.3 Raytheon Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 Raytheon Bionic Exoskeletons Product Offerings
7.13.5 Raytheon Recent Developments
7.14 General Dynamics
7.14.1 General Dynamics Company Information
7.14.2 General Dynamics Introduction and Business Overview
7.14.3 General Dynamics Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2021–2026)
7.14.4 General Dynamics Bionic Exoskeletons Product Offerings
7.14.5 General Dynamics Recent Developments
7.15 Honeywell
7.15.1 Honeywell Company Information
7.15.2 Honeywell Introduction and Business Overview
7.15.3 Honeywell Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2021–2026)
7.15.4 Honeywell Bionic Exoskeletons Product Offerings
7.15.5 Honeywell Recent Developments
7.16 Bionic Power
7.16.1 Bionic Power Company Information
7.16.2 Bionic Power Introduction and Business Overview
7.16.3 Bionic Power Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2021–2026)
7.16.4 Bionic Power Bionic Exoskeletons Product Offerings
7.16.5 Bionic Power Recent Developments
8 Industry Chain Analysis
8.1 Bionic Exoskeletons Industrial Chain
8.2 Bionic Exoskeletons Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Bionic Exoskeletons Sales Model
8.5.2 Sales Channels
8.5.3 Bionic Exoskeletons Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Bionic Exoskeletons market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 132
USD 2900.00
(Single User License)
The global Bionic Exoskeletons market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-30
Pages: 174
USD 4900.00
(Single User License)
The global Bionic Exoskeletons market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 110
USD 4250.00
(Single User License)
The global market for Bionic Exoskeletons was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 144
USD 3950.00
(Single User License)
The global market for Bionic Exoskeletons was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-25
Pages: 104
USD 2900.00
(Single User License)
The global Bionic Exoskeletons market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-15
Pages: 113
USD 4900.00
(Single User License)
The global market for Bionic Exoskeletons was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-16
Pages: 138
USD 3950.00
(Single User License)
The global Bionic Exoskeletons market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-04
Pages: 102
USD 2900.00
(Single User License)
The global Bionic Exoskeletons market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 132
The global Bionic Exoskeletons market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-30
Pages: 174
The global Bionic Exoskeletons market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 110
The global market for Bionic Exoskeletons was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 144
The global market for Bionic Exoskeletons was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-25
Pages: 104
The global Bionic Exoskeletons market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-15
Pages: 113
The global market for Bionic Exoskeletons was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-16
Pages: 138
The global Bionic Exoskeletons market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-04
Pages: 102
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now